Diagnostic Microbiology & Infectious Disease
Volume 66, Issue 3 , Pages 285-291 , March 2010

Surface gene mutations of hepatitis B virus among high-risk patients with occult hepatitis B virus infection

  • Rasool Hamkar

      Affiliations

    • Tehran University of Medical Sciences, Tehran 14155, Iran
    • ,
  • Arezoo Aghakhani

      Affiliations

    • Clinical Research Department, Pasteur Institute of Iran, Tehran 13164, Iran
    • ,
  • Safyeh Soufian

      Affiliations

    • Arak Payame Noor University, Arak 38135, Iran
    • ,
  • Mohammad Banifazl

      Affiliations

    • Iranian Society for Support Patients with Infectious Diseases, Tehran 19568, Iran
    • ,
  • Nastaran Ghavami

      Affiliations

    • Tehran University of Medical Sciences, Tehran 14155, Iran
    • ,
  • Mahsa Nadri

      Affiliations

    • Tehran University of Medical Sciences, Tehran 14155, Iran
    • ,
  • Masoomeh Sofian

      Affiliations

    • Arak University of Medical Sciences, Arak 38149, Iran
    • ,
  • Farrokhlagha Ahmadi

      Affiliations

    • Tehran University of Medical Sciences, Tehran 14155, Iran
    • ,
  • Effat Razeghi

      Affiliations

    • Tehran University of Medical Sciences, Tehran 14155, Iran
    • ,
  • Ali Eslamifar

      Affiliations

    • Clinical Research Department, Pasteur Institute of Iran, Tehran 13164, Iran
    • ,
  • Amitis Ramezani

      Affiliations

    • Clinical Research Department, Pasteur Institute of Iran, Tehran 13164, Iran
    • Corresponding Author InformationCorresponding author. Tel.: +98-2166968852; fax: +98-2166465147.

Received 2 August 2009 ,Accepted 6 October 2009.

References 

  1. Ackerman Z, Wands JR, Gazitt Y, Brechot C, Kew MC, Shouval D. Enhancement of HBsAg detection in serum of patients with chronic liver disease following removal of circulating immune complexes. J. Hepatol. 1994;20:398–404
  2. Aghakhani A, Hamkar R, Zamani N, Eslamifar A, Banifazl M, Saadat A, et al. Hepatitis B virus genotype in Iranian patients with hepatocellular carcinoma. Int. J. Infect. Dis. 2009;
  3. Alhababi F, Sallam TA, Tong CY. The significance of “anti-HBc only” in the clinical virology laboratory. J. Clin. Virol. 2003;27:162–169
  4. Araujo NM, Branco-Vieira M, Silva AC, Pilotto JH, Grinsztejn B, de Almeida AJ, et al. Occult hepatitis B virus infection in HIV-infected patients: evaluation of biochemical, virological and molecular parameters. Hepatol. Res. 2008;38:1194–1203
  5. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely “occult”?. Hepatology. 2001;34:194–203
  6. Carman WF. The clinical significance of surface antigen variants of hepatitis B virus. J. Viral Hepat. 1997;4(Suppl. 1):11–20
  7. Carman WF, Korula J, Wallace L, MacPhee R, Mimms L, Decker R. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet. 1995;345:1406–1407
  8. Chemin I, Zoulim F, Merle P, Arkhis A, Chevallier M, Kay A, et al. High incidence of hepatitis B infection among chronic hepatitis cases of unknown aetiology. J. Hepatol. 2001;34:447–454
  9. Chen YC, Delbrook K, Dealwis C, Mimms L, Mushawar I, Mandecki W. Discontinuous epitopes of hepatitis B surface antigen derived from a filamentous phage peptide library. PNAS USA. 1996;93:1997–2001
  10. Cooreman MP, van Roosmalen MH, te Morsche R, Sünnen CM, de Ven EM, Jansen JB, et al. Characterization of the reactivity pattern of murine monoclonal antibodies against wild-type hepatitis B surface antigen to G145R and other naturally occurring “a” loop escape mutations. Hepatology. 1999;30:1287–1292
  11. Datta S, Banerjee A, Chandra PK, Chakraborty S, Basu SK, Chakravarty R. Detection of a premature stop codon in the surface gene of hepatitis B virus from an HBsAg and antiHBc negative blood donor. J. Clin. Virol. 2007;40:255–258
  12. Fang Y, Teng X, Xu WZ, Li D, Zhao HW, Fu LJ, et al. Molecular characterization and functional analysis of occult hepatitis B virus infection in Chinese patients infected with genotype C. J. Med. Virol. 2009;81:826–835
  13. Felsenstein J. Confidence limits on phylogenesis: an approach using the bootstrap. Evolution. 1985;39:783–791
  14. Grethe S, Monazahian M, Bohme I, Thomssen R. Characterization of unusual escape variants of hepatitis B virus isolated from hepatitis B surface antigen-negative subjects. J. Virol. 1998;72:7692–7696
  15. Grob P, Jilg W, Bornhak H, Gerken G, Gerlich W, Gunther S, et al. Serological pattern “anti-HBc alone”: report on a workshop. J. Med. Virol. 2000;62:4505
  16. Hou J, Karayiannis P, Waters J, Luo K, Liang C, Thomas HC. A unique insertion in the S gene of surface antigen–negative hepatitis B virus Chinese carriers. Hepatology. 1995;21:273–278
  17. Hou J, Wang Z, Cheng J, Lin Y, Lau GK, Sun J, et al. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology. 2001;34:1027–1034
  18. Hu KQ. Occult hepatitis B virus infection and its clinical implications. J. Viral Hepat. 2002;9:243–257
  19. Ireland JH, O'Donnell B, Basuni AA, Kean JD, Wallace LA, Lau GK, et al. Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays. Hepatology. 2000;31:1176–1182
  20. Jilg W, Hottentrager B, Weinberger K, Schlottmann K, Frick E, Holstege A, et al. Prevalence of markers of hepatitis B in the adult German population. J. Med. Virol. 2001;63:96–102
  21. Kao JH, Chen PJ, Lai MY, Chen DS. Sequence analysis of pre-S/surface and pre-core/core promoter genes of hepatitis B virus in chronic hepatitis C patients with occult HBV infection. J. Med. Virol. 2002;68:216–220
  22. Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol. 1980;16:111–120
  23. Liang TJ, Blum HE, Wands JR. Characterization and biological properties of a hepatitis B virus isolated from a patient without hepatitis B virus serologic markers. Hepatology. 1990;12:204–212
  24. Mohebbi SR, Amini-Bavil-Olyaee S, Zali N, Noorinayer B, Derakhshan F, Chiani M, et al. Molecular epidemiology of hepatitis B virus in Iran. Clin. Microbiol. Infect. 2008;14:858–866
  25. Ozaslan M, Ozaslan E, Barsgan A, Koruk M. Mutations in the S gene region of hepatitis B virus genotype D in Turkish patients. J. Genet. 2007;86:195–201
  26. Pichoud C, Seigneres B, Wang ZR, Trep C, Zoulim F. Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance. Hepatology. 1999;29:230–237
  27. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 1987;4:406–425
  28. Sakugawa H, Nakasone H, Nakayoshi T, Kawakami Y, Yamashiro T, Maeshiro T, et al. Hepatitis B virus concentrations in serum determined by sensitive quantitative assays in patients with established chronic hepatitis delta virus infection. J. Med. Virol. 2001;65:478–484
  29. Seddigh-Tonekaboni S, Waters JA, Jeffers S, Gehrke R, Ofenloch B, Horsch A, et al. Effect of variation in the common “a” determinant on the antigenicity of hepatitis B surface antigen. J. Med. Virol. 2000;60:113–121
  30. Tang JH, Yeh CT, Chen TC, Hsieh SY, Chu CM, Liaw YF. Emergence of an S gene mutant during thymosin alpha1 therapy in a patient with chronic hepatitis B. J. Infect. Dis. 1998;178:866–869
  31. Wakil SM, Kazim SN, Khan LA, Raisuddin S, Parvez MK, Guptan RC, et al. Prevalence and profile of mutations associated with lamivudine therapy in Indian patients with chronic hepatitis B in the surface and polymerase genes of hepatitis B virus. J. Med. Virol. 2002;68:311–318
  32. Waters JA, Kennedy M, Voet P, Hauser P, Petre J, Carman WF, et al. Loss of the common “a” determinant of hepatitis B surface antigen by a vaccine-induced escape mutant. J. Clin. Invest. 1992;90:2543–2547
  33. Weber B, Melchior W, Gehrke R, Doerr HW, Berger A, Rabenau H. Hepatitis B virus markers in anti-HBc only positive individuals. J. Med. Virol. 2001;64:312–319
  34. Weinberger KM, Bauer T, Böhm S, Jilg W. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J. Gen. Virol. 2000;81(Pt 5):1165–1174
  35. Yamamoto K, Horikita M, Tsuda F, Itoh K, Akahane Y, Yotsumoto S, et al. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J. Virol. 1994;68:2671–2676
  36. Yang X, Tang XP, Lei JH, Luo HY, Zhang YH. Novel stop codon mutation in HBsAg gene identified in a hepatitis B virus strain associated with cryptogenic cirrhosis. World J. Gastroenterol. 2003;9:1516–1520
  37. Zeng GB, Wen SJ, Wang ZH, Yan L, Sun J, Hou JL. A novel hepatitis B virus genotyping system by using restriction fragment length polymorphism patterns of S gene amplicons. World J. Gastroenterol. 2004;10:3132–3136
  38. Zuckerman AJ. Effect of hepatitis B virus mutants on efficacy of vaccination. Lancet. 2000;355:1382–1384

PII: S0732-8893(09)00416-7

doi: 10.1016/j.diagmicrobio.2009.10.006

Diagnostic Microbiology & Infectious Disease
Volume 66, Issue 3 , Pages 285-291 , March 2010

Article Tools

* Image Usage & Resolution